Last reviewed · How we verify
NCT03607409
Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
trial in Infertility in 150 participants. Completed in 4 July 2019.
29 January 2019
Quick facts
| Lead sponsor | ART Fertility Clinics LLC |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 9 September 2018 |
| Primary completion | 29 January 2019 |
| Estimated completion | 4 July 2019 |
| Sites | 1 location across United Arab Emirates |
Conditions studied
- Infertility — all drugs for Infertility →
Sponsor
ART Fertility Clinics LLC
Who can join
Adults 18 to 40, female only, with Infertility. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate the role of Inhibin A as bio marker for the number of mature oocytes, compared to Estradiol
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Inhibin A-A Promising Predictive Parameter for Determination of Final Oocyte Maturation in Ovarian Stimulation for IVF/ICSI.
Lawrenz B, Depret Bixio L, Coughlan C, Andersen CY, et al · · 2020 · cited 7× · PMID 32499758 · DOI 10.3389/fendo.2020.00307
Verify or expand the search:
- PubMed search for NCT03607409
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Infertility
Currently open trials in the same condition.
- NCT07074015 — IntelliWell: An AI-Assisted Imaging Platform for Detection and Location of Ultra-Rare Testicular Sperm in Surgical Speci · NA · recruiting
- NCT07358468 — Impact Of FET Preparation Protocol On Endometrial Peristalsis: A Prospective Cohort Study · recruiting
- NCT07340827 — A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH · Phase 3 · recruiting
- NCT07369362 — To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That · NA · active not recruiting
- NCT07153367 — Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauter · Phase 2 · recruiting
Other ART Fertility Clinics LLC trials
Trials by the same sponsor.
- NCT07270250 — Impact of Dry vs Humidified Culture Conditions on Blastocyst Development and Aneuploidy: A Time-lapse Sibling Oocyte Stu · NA · not yet recruiting
- NCT06879002 — Comparing IVF/ICSI Cycle Outcomes of Post Ovulation Ovarian Stimulation Protocol With Elonva Without GnRH Antagonist to · not yet recruiting
- NCT07093619 — Evaluating the Utility of Implementing Microfluids for Sperm Preparation Compared to Conventional Method of Density Grad · NA · recruiting
- NCT06732843 — Does Recombinant FSH (rFSH, i.g. Gonal F®) as Compared to Human Menopausal Gonadotrophin (hMG) Affect Telomere Length of · recruiting
- NCT07014267 — Virtual Reality for Mindfulness and Anxiety Reduction in Fertility Procedures · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03607409 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by ART Fertility Clinics LLC
- Last refreshed: 8 August 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03607409.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing